Automated Suturing Devices Market
By Type;
Disposable and ReusableBy Application;
Cardiac, Orthopedic, Ophthalmic, Dental, Gynecological, and OthersBy End Use;
Hospitals & Clinics, Ambulatory Surgical Centres, and OthersBy Geography;
North America, Europe, Asia Pacific, Middle East &T Africa, and Latin America - Report Timeline (2021 - 2031)Automated Suturing Devices Market Overview
Automated Suturing Devices Market (USD Million)
Automated Suturing Devices Market was valued at USD 666.56 million in the year 2024. The size of this market is expected to increase to USD 1,015.57 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 6.2%.
Automated Suturing Devices Market
*Market size in USD million
CAGR 6.2 %
Study Period | 2025 - 2031 |
---|---|
Base Year | 2024 |
CAGR (%) | 6.2 % |
Market Size (2024) | USD 666.56 Million |
Market Size (2031) | USD 1,015.57 Million |
Market Concentration | Medium |
Report Pages | 330 |
Major Players
- Ethicon, Inc.
- Medtronic Plc
- B. Braun Melsungen AG
- Smith& Nephew Plc
- Apollo Endosurgery, Inc.
- DemeTECH Corporation
- EndoEvolution, LLC.
- Apollo Endosurgery, Inc.
- Surgical Specialties Corporation
- Mellon Medical B.V.
Market Concentration
Consolidated - Market dominated by 1 - 5 major players
Automated Suturing Devices Market
Fragmented - Highly competitive market without dominant players
The Automated Suturing Devices Market is advancing through key technological advancements, with over 60% of development dedicated to robotic and automated needle guidance systems. These tools enhance efficacy, delivering reliable suturing quality and reducing surgeon workload. Improved outcomes are driving consistent growth and encouraging widespread clinical integration.
Joint Innovation Accelerating Scalability and Training
Nearly 50% of device rollouts result from collaboration and partnerships among manufacturers, surgical academies, and hospital teams. These strategies improve usability, streamline training protocols, and support validation studies. Coordinated efforts facilitate expansion across various surgical specialties.
Mergers Enabling Platform Integration and Support
Close to 35% of market acceleration comes from merger activity linking suturing device innovators with robotic systems and analytics platforms. These alliances enhance technological capabilities, increase production precision, and optimize delivery networks. The consolidation supports scalable expansion of advanced suturing ecosystems.
Data‑Driven Feedback Enhancing Surgical Quality
With over 50% of operating rooms adopting AI‑based monitoring and feedback platforms, suture performance tracking is becoming standard. These systems provide real‑time tension data, stitch consistency reports, and performance metrics. The union of digital oversight and device design exemplifies technological advancements, delivering sustained growth and a forward‑leaning future outlook in surgical care.
Automated Suturing Devices Market Recent Developments
-
In April 2021, Medtronic announced its partnership with Surgical Theater, a startup that markets a Surgery Rehearsal Platform. With the initiative, the companies focused on integrating SynAR's augmented reality of Surgical Theater with Medtronic's StealthStation S8 surgical navigation system. In addition, Medtronic is likely to allow surgeons to increase their outputs by providing ingenious technologies to them
-
In January 2022, Endomina, an endoscopic medical suture device developed an endo tools therapeutics, was approved by the United States Food and Drug Administration for endoscopic placement of sutures in the gastrointestinal tract in the adult population.
Automated Suturing Devices Market Segment Analysis
In this report, the Automated Suturing Devices Market has been segmented by Type, Application, End Use and Geography.
Automated Suturing Devices Market, Segmentation by Type
The Automated Suturing Devices Market has been segmented by Type into Disposable and Reusable.
Disposable
The disposable segment dominates the automated suturing devices market, accounting for nearly 65–68% of the share due to ease of use, reduced risk of cross-contamination, and elimination of sterilization costs. These devices are particularly popular in high-volume surgical centers and emergency procedures where time efficiency is crucial.
Reusable
Reusable automated suturing devices hold approximately 32–35% of the market, driven by cost-effectiveness in long-term use and preference in specialized surgeries. They are favored by institutions with established sterilization facilities and those aiming to reduce medical waste.
Automated Suturing Devices Market, Segmentation by Application
The Automated Suturing Devices Market has been segmented by Application into Cardiac, Orthopedic, Ophthalmic, Dental, Gynecological and Others.
Cardiac
The cardiac segment accounts for about 28–30% of the automated suturing devices market, driven by the rising prevalence of cardiovascular diseases and the increasing number of open-heart and minimally invasive surgeries. Precision and speed in suturing are critical in these procedures to reduce operative time and improve patient recovery.
Orthopedic
Orthopedic applications hold around 22–24% of the market, supported by growing incidences of bone fractures, sports injuries, and joint replacement surgeries. Automated suturing devices improve surgical efficiency in procedures like tendon repairs and ligament reconstructions.
Ophthalmic
Ophthalmic surgeries represent approximately 10–12% of the market, benefiting from the need for precision in delicate eye procedures such as corneal transplants and cataract surgeries. These devices minimize trauma to surrounding tissues and enhance surgical outcomes.
Dental
Dental applications contribute nearly 8–10% of the share, mainly due to rising demand for dental implants, periodontal surgeries, and maxillofacial reconstructions. Automated suturing ensures better control and reduced operative time in complex oral procedures.
Gynecological
Gynecological surgeries hold about 15–17% of the market, with demand fueled by procedures such as cesarean sections, hysterectomies, and pelvic repairs. These devices help improve surgical accuracy and reduce postoperative complications.
Others
The ‘Others’ category, comprising general, urological, and plastic surgeries, accounts for roughly 8–9%. Automated suturing devices in these applications provide versatility and time efficiency across varied surgical specialties.
Automated Suturing Devices Market, Segmentation by End Use
The Automated Suturing Devices Market has been segmented by End Use into Hospitals & Clinics, Ambulatory Surgical Centres and Others.
Hospitals & Clinics
Hospitals & clinics dominate the automated suturing devices market with an estimated 65–68% share, driven by the high volume of complex surgical procedures and the presence of specialized surgical teams. These settings often prioritize advanced suturing technologies to improve surgical outcomes and reduce operative time.
Ambulatory Surgical Centres
Ambulatory surgical centres account for around 22–25% of the market, benefiting from the growing preference for same-day surgeries and cost-effective treatment options. The use of automated suturing devices in these facilities supports faster patient turnover and efficient wound closure.
Others
The ‘Others’ segment, which includes specialty clinics, research institutions, and military medical facilities, holds approximately 8–10% of the market. Adoption here is driven by the need for portable and precise suturing solutions in specialized and field-based medical environments.
Automated Suturing Devices Market, Segmentation by Geography
In this report, the Automated Suturing Devices Market has been segmented by Geography into five regions; North America, Europe, Asia Pacific, Middle East & Africa and Latin America.
Regions and Countries Analyzed in this Report
Automated Suturing Devices Market Share (%), by Geographical Region
North America
North America holds the largest share of the automated suturing devices market at approximately 38–40%, supported by a high volume of surgical procedures, advanced healthcare infrastructure, and strong adoption of minimally invasive technologies. The presence of leading manufacturers also contributes to regional dominance.
Europe
Europe accounts for around 27–29% of the market, driven by increased investment in surgical innovations, a strong network of specialized surgical centres, and favourable government healthcare policies that encourage technology adoption.
Asia Pacific
Asia Pacific represents approximately 22–24% of the market, fueled by growing healthcare expenditure, a rising number of elective and trauma surgeries, and expanding medical device manufacturing capabilities in countries like China, Japan, and India.
Middle East & Africa
Middle East & Africa holds a smaller share of about 5–7%, with growth supported by improvements in surgical facilities and medical tourism in countries like the UAE and South Africa. Adoption is slower due to budget constraints in certain areas.
Latin America
Latin America captures roughly 4–5% of the market, with demand rising from public and private hospital expansions and the gradual integration of advanced surgical tools in countries like Brazil and Mexico.
Market Trends
This report provides an in depth analysis of various factors that impact the dynamics of Global Automated Suturing Devices Market. These factors include; Market Drivers, Restraints and Opportunities Analysis.
Drivers, Restraints and Opportunity Analysis
Drivers:
- Minimally Invasive Surgery Demand
- Surge in Surgical Procedures
- Improved Patient Outcomes
-
Healthcare Expenditure Rise -The global automated suturing devices market is experiencing a notable surge, significantly influenced by the rising healthcare expenditure worldwide. This increase in healthcare spending is a pivotal driver, enabling the adoption and integration of advanced medical technologies, including automated suturing devices, across various healthcare settings. Governments and private sectors are allocating substantial resources to enhance healthcare infrastructure, improve patient care, and incorporate cutting-edge medical innovations. This financial commitment is crucial in fostering an environment conducive to the growth and widespread adoption of automated suturing devices.
In developed countries, healthcare expenditure has consistently increased, driven by the need to address an aging population, the prevalence of chronic diseases, and the demand for high-quality medical care. These nations are at the forefront of adopting advanced surgical technologies to improve procedural outcomes and patient safety. Automated suturing devices, with their ability to enhance surgical precision and reduce operative times, align perfectly with these healthcare objectives. As a result, hospitals and surgical centers in these regions are increasingly investing in such technologies, further propelling market growth.
Emerging economies are also witnessing a significant rise in healthcare spending, spurred by economic growth, urbanization, and a greater focus on improving healthcare services. Governments in these regions are prioritizing healthcare reforms and infrastructural development, which includes the procurement of advanced medical devices. The increased healthcare budget is facilitating the adoption of automated suturing devices in hospitals and clinics, aiming to elevate the standard of surgical care. Additionally, international collaborations and investments are playing a crucial role in making these advanced devices accessible in developing countries, thereby expanding the market reach.
The growing awareness among healthcare professionals and patients about the benefits of automated suturing devices is another factor driving market growth. These devices offer numerous advantages, such as reduced risk of infections, minimal tissue trauma, and faster recovery times, which are crucial for enhancing patient outcomes. With rising healthcare expenditure, there is a greater capacity for training medical personnel in the use of these sophisticated devices, ensuring their effective implementation in surgical procedures. This educational investment is vital for maximizing the potential benefits of automated suturing technologies, thereby contributing to their increased adoption.
The strategic initiatives by key market players, including mergers, acquisitions, and partnerships, are bolstered by the increased availability of funds through heightened healthcare expenditure. These collaborations aim to innovate and expand product offerings, ensuring that the latest advancements in automated suturing technology reach a broader market. The financial support for research and development activities is essential for the continuous improvement and refinement of these devices, addressing the evolving needs of the healthcare sector.
In conclusion, the rise in healthcare expenditure globally is a fundamental catalyst for the growth of the automated suturing devices market. This financial upsurge is enabling healthcare systems to adopt advanced surgical technologies, improve patient care, and meet the increasing demand for efficient and precise surgical procedures. As healthcare spending continues to escalate, the automated suturing devices market is poised for sustained expansion, driven by technological advancements, strategic industry collaborations, and a global commitment to enhancing medical care standards.
Restraints:
- High Costs
- Lack of Skilled Professionals
- Regulatory Challenges
-
Device Malfunction Risks -Automated suturing devices have revolutionized surgical procedures by offering enhanced precision, reduced procedure times, and improved patient outcomes. However, like any medical device, they also pose certain risks related to device malfunction, which need careful consideration:
Mechanical failures in automated suturing devices can occur due to issues such as manufacturing defects, wear and tear over time, or improper maintenance. These failures may result in the device not functioning correctly during a surgical procedure, potentially leading to incomplete sutures or procedural delays.
Automated suturing devices often incorporate software and electronic components to control suturing patterns and mechanisms. Malfunctions in these components can occur due to software bugs, electrical faults, or compatibility issues with other surgical equipment. Such malfunctions may disrupt the surgical workflow and compromise the safety and effectiveness of the suturing process.
Issues related to the feeding of needles or sutures through the device can arise, leading to misalignment, jamming, or improper tensioning during suturing. These problems can affect the quality and consistency of sutures placed, potentially requiring manual intervention and increasing surgical time and complexity.
Integration of automated suturing devices with other surgical equipment and instruments can present compatibility challenges. Incompatibilities may lead to operational errors, interruptions in surgical flow, or inadequate suturing outcomes. Ensuring proper training and familiarization with device interfaces is crucial to mitigate such risks.
User error, often stemming from inadequate training or experience with automated suturing devices, can contribute significantly to device-related malfunctions. Improper handling, incorrect setup, or misunderstanding of device functionalities may result in operational errors, compromising surgical outcomes and patient safety.
Compliance with regulatory standards and ongoing quality assurance practices are essential to mitigate device malfunction risks in the automated suturing devices market. Manufacturers must adhere to stringent regulatory requirements and conduct rigorous testing to ensure device reliability, performance, and safety.
In conclusion, while automated suturing devices offer substantial benefits in modern surgical practice, healthcare providers and manufacturers must remain vigilant about potential device malfunction risks. Addressing these risks through comprehensive training, regular maintenance, and adherence to regulatory standards is essential to enhance patient safety and optimize surgical outcomes.
Opportunities:
- Product Innovation
- Telemedicine Integration
- Growing Geriatric Population
-
Government Initiatives -Government initiatives play a significant role in shaping the global automated suturing devices market, particularly in terms of regulation, healthcare policies, and funding initiatives. Regulatory bodies such as the FDA (Food and Drug Administration) in the United States and their equivalents in other countries oversee the approval and market entry of automated suturing devices. These regulations ensure that devices meet stringent safety and efficacy standards before they can be marketed and used in clinical settings. Government regulations also guide manufacturers in conducting clinical trials and obtaining necessary approvals, which can influence the timeline and costs associated with bringing new devices to market.
Healthcare policies and initiatives by governments worldwide impact the adoption and utilization of automated suturing devices. Policies that prioritize healthcare infrastructure development, improvement of surgical outcomes, and reduction of healthcare-associated infections can drive the demand for advanced medical devices, including automated suturing devices. Governments may also support initiatives to promote innovation in medical technology through funding research and development efforts or providing incentives for healthcare facilities to upgrade their equipment.
Government funding and reimbursement policies play a crucial role in the market dynamics of automated suturing devices. Reimbursement policies affect the financial viability of using advanced medical devices in clinical practice, influencing healthcare providers' purchasing decisions and adoption rates. Governments may offer reimbursement schemes or subsidies to encourage healthcare facilities to invest in technologies that improve patient outcomes and operational efficiency.
In summary, government initiatives encompass regulatory oversight, healthcare policies, funding support, and reimbursement strategies, all of which contribute to shaping the global automated suturing devices market. These initiatives aim to ensure patient safety, promote innovation, and enhance the accessibility and affordability of advanced medical technologies in healthcare systems worldwide.
Competitive Landscape Analysis
Key players in Global Pericarditis Market include :
- Ethicon, Inc.
- Medtronic Plc
- B. Braun Melsungen AG
- Smith& Nephew Plc
- Apollo Endosurgery, Inc.
- DemeTECH Corporation
- EndoEvolution, LLC.
- Apollo Endosurgery, Inc.
- Surgical Specialties Corporation
- Mellon Medical B.V.
In this report, the profile of each market player provides following information:
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Introduction
- Research Objectives and Assumptions
- Research Methodology
- Abbreviations
- Market Definition & Study Scope
- Executive Summary
- Market Snapshot, By Type
- Market Snapshot, By Application
- Market Snapshot, By End Use
- Market Snapshot, By Region
- Automated Suturing Devices Market Dynamics
- Drivers, Restraints and Opportunities
- Drivers
-
Minimally Invasive Surgery Demand
-
Surge in Surgical Procedures
-
Improved Patient Outcomes
-
Healthcare Expenditure Rise
-
- Restraints
-
High Costs
-
Lack of Skilled Professionals
-
Regulatory Challenges
-
Device Malfunction Risks
-
- Opportunities
-
Product Innovation
-
Telemedicine Integration
-
Growing Geriatric Population
-
Government Initiatives
-
- Drivers
- PEST Analysis
- Political Analysis
- Economic Analysis
- Social Analysis
- Technological Analysis
- Porter's Analysis
- Bargaining Power of Suppliers
- Bargaining Power of Buyers
- Threat of Substitutes
- Threat of New Entrants
- Competitive Rivalry
- Drivers, Restraints and Opportunities
- Market Segmentation
- Automated Suturing Devices Market, By Type, 2021 - 2031 (USD Million)
- Disposable
- Reusable
- Automated Suturing Devices Market, By Application, 2021 - 2031 (USD Million)
- Cardiac
- Orthopedic
- Ophthalmic
- Dental
- Gynecological
- Others
- Automated Suturing Devices Market, By End Use, 2021 - 2031 (USD Million)
- Hospitals & Clinics
- Ambulatory Surgical Centres
- Others
- Automated Suturing Devices Market, By Geography, 2021 - 2031 (USD Million)
- North America
- United States
- Canada
- Europe
- Germany
- United Kingdom
- France
- Italy
- Spain
- Nordic
- Benelux
- Rest of Europe
- Asia Pacific
- Japan
- China
- India
- Australia & New Zealand
- South Korea
- ASEAN (Association of South East Asian Countries)
- Rest of Asia Pacific
- Middle East & Africa
- GCC
- Israel
- South Africa
- Rest of Middle East & Africa
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- North America
- Automated Suturing Devices Market, By Type, 2021 - 2031 (USD Million)
- Competitive Landscape
- Company Profiles
- Ethicon, Inc.
- Medtronic Plc
- B. Braun Melsungen AG
- Smith& Nephew Plc
- Apollo Endosurgery, Inc.
- DemeTECH Corporation
- EndoEvolution, LLC.
- Apollo Endosurgery, Inc.
- Surgical Specialties Corporation
- Mellon Medical B.V.
- Company Profiles
- Analyst Views
- Future Outlook of the Market